Vimarsana
Biggest News Aggregation in the World

Takeda Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Takeda Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Takeda Ventures Today - Breaking & Trending Today

Pharmaceutical giant Takeda is shutting down its San Diego office - Vimarsana News

Pharmaceutical giant Takeda is shutting down its San Diego office

The plant closure is part of a broader restructuring at Takeda. The closure affects more than 300 San Diego workers who will either be laid off or relocated.

Harness Therapeutics appoints experienced biopharma exec as Chair - Vimarsana News

Harness Therapeutics appoints experienced biopharma exec as Chair

Experienced biopharma executive Meenu Chhabra Karson has been appointed Chair of the Board at Cambridge-based Harness Therapeutics.

MaxCyte Signs Strategic Platform License with Be Biopharma - Vimarsana News

MaxCyte Signs Strategic Platform License with Be Biopharma

Be Biopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform within its Engineered B Cell Medicines programs...

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B - Vimarsana News

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-101, Produces Active and Sustained Levels of Factor IX for the Treatment of Hemophilia B

SAN DIEGO--(BUSINESS WIRE)--Dec 10, 2023--

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-1 - Vimarsana News

Be Bio Announces New Preclinical Data Demonstrating its Novel Engineered B Cell Medicine (BCM), BE-1

BE-101 is Company’s Lead Program in Hemophilia B; IND Filing Anticipated in Mid-2024Be Bio Appoints Glenn Pierce, M.D., Ph.D., Hemophilia Physician-Researcher and Advocate, to its Scientific Advisory BoardPreclinical Study Findings Shared in Oral Presentation During 65th Annual Meeting of the American Society of Hem...